Takeda Pharmaceutical Co Ltd (TKPHF) bonds

TKPHFOTCPharmaceutical PreparationsAlso trades as TAK

Financials through fiscal 2026, year ended Mar 31, 2026Last filing: 20-F on Jun 17, 2026Score 5/30

$39.00+0.36 (+0.93%)

Close on Oct 19, 2026Market cap $134.41BP/E –Yield –

Debt

Borrowings on the balance sheet, Mar 31, 2026

Total debt

¥4.88T

¥512.16B due within a year

Net debt

¥4.29T

After ¥595.05B of cash

Implied interest rate

7.61%

FY2026 interest ÷ average debt

Interest coverage

0.0×

FY2026 operating income ÷ interest

Long-term plus current debt, JPY

Individual notes, bonds and loans

The debt footnote in the annual report has no machine-readable detail for individual notes, so coupons and maturities cannot be listed.

Parsed from the XBRL in Takeda Pharmaceutical's annual and quarterly filings with the SEC
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is TKPHF.

Revenue growth-1.7% · median 16.2%

Gross margin65.1% · median 78.4%

Net margin-3.4% · median 19.3%

Advertisement
300 × 250